Nexalin Technology unveils positive results of clinical study for Gen-2 tACS device

Investor Relations, Videos

April 18, 2024 12:07 PM

Link to site HERE.

Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer’s Program Amid Encouraging Data

May 13, 2025

Nexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public Offering

May 6, 2025

Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock

May 5, 2025